Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
vitaliana.desanctis@uniroma1.it
Vitaliana De Sanctis
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
vitaliana.desanctis@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Mono-and Bi-weekly hypofractionated radiation therapy for the treatment of epithelial skin cancer in very elderly patients
ANTICANCER RESEARCH
2017
Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients. outcomes and prognostic factors after long-term follow-up
CLINICAL COLORECTAL CANCER
2017
Renin-angiotensin system inhibitors might help to reduce the development of symptomatic radiation pneumonitis after stereotactic body radiotherapy for lung cancer
CLINICAL LUNG CANCER
2016
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2016
Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy
RADIATION ONCOLOGY
2016
Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS
2015
Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade: In vitro study
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
2015
Sepsis in head and neck cancer patients treated with chemotherapy and radiation. Literature review and consensus
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2015
Multifraction radiotherapy for palliation of painful bone metastases. 20 Gy versus 30 Gy
TUMORI
2015
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies. Literature review and consensus
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2015
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors. Literature review and consensus
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2015
Maternal thrombophilia and adverse pregnancy outcome: a case-control study
ACTA HAEMATOLOGICA
2015
Severe and prolonged myelosuppression during concomitant temozolomide and radiotherapy treatment in a patient with glioblastoma multiforme
INTERNATIONAL JOURNAL OF MEDICAL AND PHARMACEUTICAL CASE REPORTS
2015
Radiation-induced malignant meningioma following proton beam therapy for a choroidal melanoma
JOURNAL OF CLINICAL NEUROSCIENCE
2015
Stereotactic body radiation therapy for liver lesions. A single-institution experience
ANTICANCER RESEARCH
2015
Radiation oncology in Italy. The past, the present, the future
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2015
Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients
ANTICANCER RESEARCH
2015
Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up
ANTICANCER RESEARCH
2015
Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
ANTICANCER RESEARCH
2015
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma
PRACTICAL RADIATION ONCOLOGY
2015
« prima
< precedente
1
2
3
4
Progetti di Ricerca
Ruolo del Regorafenib come opzione terapeutica di II linea nelle recidive di glioblastoma: valutazione dei benefici nei pazienti già sottoposti a trattamento radioterapico e chemioterapico con temozolomide.
Impatto della moderna radioterapia sulla sopravvivenza dei pazienti con diagnosi di linfoma (Hodgkin e non Hodgkin) diagnosticati nella Regione Lazio dal 2013 al 2017: un modello epidemiologico real-life.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma